Rowan (RDC) was upgraded at Duncan-Williams to Strong Buy from Sell. $54 price target. Last quarter should prove to be a low point in earnings, Duncan-Williams said.
Transocean (RIG) was upgraded at Global Hunter to Neutral from Reduce. Stock is pricing in the company's lower earnings potential, Global Hunter said.
Scotts Miracle-Gro (SMG) was downgraded at RBC Capital to Sector Perform from Outperform. $61 price target. Company faces increased sales risk given the weather shift, RBC said.
Valueclick (VCLK) was upgraded at Merriman Capital to Buy. Acquisitions are helping to drive growth, Merriman said.Valueclick was upgraded at Jefferies from Hold to Buy. $20 price target. Core segments could see increased growth potential, Jefferies said. Valueclick was upgraded at Needham from Hold to Buy. $25 price target. Company is seeing improved margins, Needham said. Vertex Pharmaceuticals (VRTX) was downgraded at Brean Murray from Buy to Hold. Valuation call, based on a $53 price target, Brean Murray said.
End of report.